Drugs in development as of January 2008 for the treatment of actinic keratosis, melanoma, andpsoriasis
Selected websites
http://www.aad.org/
American Academy of Dermatology
http://www.nlm.nih.gov/medlineplus/psoriasis.html
MedlinePlus health information on psoriasis
http://www.niams.nih.gov/
National Institute of Arthritis and Musculoskeletal and Skin Diseases
http://www.psoriasis.org/
National Psoriasis Foundation
Navitus to Offer Unbranded Stelara Biosimilar, Remove Stelara from Formulary
March 13th 2025Lumicera Health Services, Navitus’ specialty pharmacy, has made a deal with Teva to offer an unbranded biosimilar that they estimate will save $112,000 and $336,000 per patient per year. Navitus will remove Stelara from formulary on July 1, 2025.
Read More